MEDITE Cancer Diagnostics, Inc. Announces Granted Patent “Lab-in-One Automation” System

MEDITE Cancer Diagnostics, Inc., (MDIT) announced the recent decision of the German Patent Register to grant MEDITE the German priority patent for its Histology “Lab-in-one Automation” System. Based on this success MEDITE will finish its nationalization applications for USA, China and UK before April 4th, 2015.

Please to read the entire article.